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REPLY
We appreciate the interest of Dr. Karamanoukian and colleagues
in our study about the relation between postoperative stroke in
cardiac surgery and presence, location and extent of atherosclerosis
in the ascending aorta (1). Our study showed a 3.5% incidence of
stroke due to atherosclerosis of the ascending aorta as detected by
epiaortic ultrasound (in 26% of the patients) despite minor surgical
modifications. Furthermore, a multivariate analysis showed that
the two best predictors for perioperative stroke were atherosclerosis
of the ascending aorta and diabetes mellitus. Age is usually
associated with atherosclerosis in the ascending aorta. Conse-
quently, atherosclerosis of the ascending aorta (detected by intra-
operative ultrasound) is a better predictor than age. Therefore, we
recommended a more radical change in surgical strategy in the
presence of atherosclerosis of the ascending aorta, and especially
when the disease of the aortic wall is extended.
One interesting option in this situation is off-pump coronary
artery bypass (OPCAB). Still, partial clamping of the ascending
aorta is usually used in OPCAB. Clamping of the ascending aorta
has been shown to generate cerebral emboli (2–5). Thus, with
OPCAB cross-clamping can be avoided, but usually partial clamp-
ing is conducted, unless an anastomotic device is employed or the
ascending aorta is totally avoided. A further possibility is the use of
intraoperative intraaortic filters, if clamping is necessary (5).
We congratulate Dr. Karamanoukian and colleagues for their
successful results with OPCAB in octogenarians. Notably, approx-
imately 12% of their patient cohort had atherosclerosis of the
ascending aorta, presumably detected by palpation. It is unclear
how these patients were handled in terms of proximal anastomosis
on the ascending aorta. Considering that their patients received
only on average 1.8 grafts, we assume that their conclusion should
be that OPCAB incomplete revascularization without touching
the ascending aorta may be the preferred operative technique in
high-risk patients (i.e., octogenerians).
Recently, we employed OPCAB to achieve complete revascu-
larization in 20 patients with extensive disease of the ascending
aorta according to intraoperative ultrasound and totally avoided the
ascending aorta in the majority of the patients. None of the 20
patients suffered a perioperative stroke.
In conclusion, we believe that OPCAB techniques may have a
justified place in high-risk patients (i.e., with extended atheroscle-
rosis the ascending aorta according to epiaortic ultrasound) in
order to prevent perioperative stroke. However, well-designed
randomized studies have to be conducted to prove the superiority
of OPCAB over conventional coronary surgery.
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Cytokine Gene Polymorphisms
and Development of
CAD Associated With CP Infection
We read with great interest the study by Momiyama et al. (1) in a
recent issue of the Journal. The study reports that cytokine gene
polymorphisms, in particular interleukin-1 (IL-1) polymorphisms,
play a role in the development of coronary artery disease (CAD) in
patients with Chlamydia pneumoniae (CP) infection. Moreover,
they found that CP seropositivity was not significantly different
between patients with and without CAD. Momiyama et al. (1)
suggested that “triggers” such as IL-1 gene polymorphisms could
influence the effect of such infectious agents as CP on development
of CAD.
Increasing evidence exists indicating that inflammation plays an
important role in atherogenesis (2). The hypothesis of infectious
agents that might play an important role in the atherogenesis is
supported by results of several epidemiologic studies suggesting
possible atherogenic potential not only from CP (3) but also from
such pathogens as cyotmegalovirus (4), herpes simplex virus (HSV)
(5) and Helicobacter pylori (6).
However, existing epidemiologic data about the association of
some of these pathogens and atherosclerosis are conflicting (7). We
support the finding of Momiyama et al. (1) that that CP seropos-
itivity is not associated with CAD by data from 218 consecutive
patients undergoing coronary angiography. Blood of all subjects
was tested for serum IgG antibodies to CP and for seromarkers of
five other pathogens (hepatitis A-virus, Helicobacter pylori, HSV,
influenza type A and influenza type B). Of the 218 patients, 88
(40.4%) had anti-CP IgG antibodies. The CAD prevalence was
61.4% in CP-seropositive and 66.9% in CP-seronegative patients
(p  0.49). Moreover, seropositivity for each other pathogen
(tested in our study) was not associated with CAD.
In contrast, the number of infectious pathogens to which an
individual has been exposed (8) (“infectious burden”) correlates
with prevalence of CAD. Four or more of the six seromarkers
tested for particular infections were positive in 48.8% of patients
with CAD and in 31.2% of patients in patients without CAD (p
0.02). Therefore, our data support the results from Momiyama et
al. (1) that seropositivity for a particular infectious agent, like CP,
represents no predictor of risk for CAD. However, some “triggers,”
such as cytokine gene polymorphisms or additional exposure to
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